Cubist Systematic Strategies, LLC Siga Technologies Inc Transaction History

Cubist Systematic Strategies, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.51 - $8.92 $474,424 - $938,330	105,194 New	105,194 $900,000
Q1 2023 May 15, 2023	SELL	$5.23 - $8.42 $1.68 Million - $2.71 Million	-321,892 Reduced 93.55%	22,197 $127,000
Q4 2022 Feb 14, 2023	SELL	$7.29 - $10.14 $1.74 Million - $2.42 Million	-238,853 Reduced 40.97%	344,089 $2.53 Million
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $2.57 Million - $6.7 Million	256,302 Added 78.47%	582,942 $6 Million
Q2 2022 Aug 15, 2022	BUY	$6.5 - $13.68 $2.12 Million - $4.47 Million	326,640 New	326,640 $3.78 Million
Q1 2022 May 16, 2022	SELL	$5.96 - $7.61 $174,484 - $222,790	-29,276 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.96 - $9.26 $82,336 - $109,545	11,830 Added 67.81%	29,276 $220,000
Q3 2021 Nov 15, 2021	BUY	$5.71 - $7.39 $99,616 - $128,925	17,446 New	17,446 $129,000
Q2 2021 Aug 16, 2021	SELL	$6.1 - $7.58 $96,422 - $119,817	-15,807 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.3 - $7.71 $53,745 - $65,774	-8,531 Reduced 35.05%	15,807 $103,000
Q4 2020 Feb 16, 2021	SELL	$6.39 - $7.76 $130,394 - $158,350	-20,406 Reduced 45.61%	24,338 $177,000
Q3 2020 Nov 16, 2020	BUY	$5.62 - $7.68 $98,327 - $134,369	17,496 Added 64.21%	44,744 $307,000
Q2 2020 Aug 14, 2020	BUY	$4.55 - $6.19 $123,978 - $168,665	27,248 New	27,248 $161,000
Q2 2019 Aug 14, 2019	SELL	$5.22 - $6.1 $67,625 - $79,025	-12,955 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.66 - $7.89 $28,384 - $39,568	-5,015 Reduced 27.91%	12,955 $78,000
Q4 2018 Feb 14, 2019	BUY	$4.77 - $7.9 $85,716 - $141,963	17,970 New	17,970 $142,000

185

35.8M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $427M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.